首页> 外国专利> ANTIBODIES SPECIFIC TO HUMAN NECTIN-2

ANTIBODIES SPECIFIC TO HUMAN NECTIN-2

机译:人类Nectin-2特异的抗体

摘要

The present dislosure provides monoclonal antibodies that recognize human Nectin-2 ( Nectin-2, Poliovirus Receptor-Related Protein-2, Poliovirus Receptor-Like 2, CDI12, or PRR-2, is a single pass transmembrane glycoprotein with two Ig-like C2-type domains and an Ig-like V-type domain) with high affinity and specificity and inhibit its binding to TIGIT and/or CD112R. The antibodies recognize the Nectin-2 protein (CD112), prevent its binding to T cell immunoreceptor with Ig and ITIM domains (TIGIT) and CD112R (PVRIG) and inhibit suppressive activity on lymphocytes such as natural killer (NK) cells and T-cells. The disclosure further provides pharmaceutical and methods for use in cancer immunotherapy and in diagnosis. The disclosure finally further provides chimeric antigen receptor (CAR) comprising scFv antibody binding to Nectin-2.
机译:本公开内容提供了识别人Nectin-2(Nectin-2,脊髓灰质炎病毒受体相关蛋白2,脊髓灰质炎病毒受体样2,CDI12或PRR-2)的单克隆抗体,该抗体是具有两个Ig样C2的单程跨膜糖蛋白型结构域和Ig样V型结构域)具有很高的亲和力和特异性,并抑制其与TIGIT和/或CD112R的结合。抗体识别Nectin-2蛋白(CD112),阻止其与具有Ig和ITIM结构域(TIGIT)和CD112R(PVRIG)的T细胞免疫受体结合,并抑制对淋巴细胞的抑制活性,例如天然杀伤(NK)细胞和T细胞。本公开进一步提供了用于癌症免疫疗法和诊断中的药物和方法。最后,本公开进一步提供了包含与Nectin-2结合的scFv抗体的嵌合抗原受体(CAR)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号